EU project boosts role of drug regulator in health technology assessments
This article was originally published in SRA
Executive Summary
EU regulators have made changes to the format of European public assessment reports (EPARs) in a bid to make it easier for health technology assessment (HTA) bodies to use the information in conducting relative effectiveness evaluations of new drugs1.